You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Risk Factors for the Development of Obesity in Children Surviving ALL and NHL

Gofman, Inessa MD*; Ducore, Jonathan MD, MPH

Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e31818c0120
Original Articles

We investigated obesity [body mass index (BMI) >95th percentile] and being heavy (BMI >85th percentile) in 95 children in first remission more than 2 years after treatment for acute lymphoblastic leukemia or non-Hodgkin lymphoma seen at our institution. Height, weight and BMI at diagnosis, end of treatment and follow-up, and blood pressure at diagnosis were adjusted by z-score for age and sex. At follow-up, obesity and overweight were not more prevalent than in the general population. Median BMI z-scores rose significantly between diagnosis (0.38) and treatment end (0.62) but not during follow-up (0.70). Median weight z-scores rose significantly during both periods (diagnosis 0.23, treatment end 0.49, and follow-up 0.68). Median height z-scores were 0.51, 0.14, and 0.16 for the same 3 time points, respectively. Repeated measures, multivariate logistic regression identified Hispanic ethnicity, younger age at diagnosis, and a positive age:weight interaction as being associated with obesity and being heavy at follow-up. There was no association with diagnosis, sex, age alone, radiation dose or field, metabolic diagnosis in patient/family, height z-score at diagnosis, duration of treatment, and systolic or diastolic blood pressure. Obesity and overweight were a combination of weight gain and height loss during treatment although weight continued to increase after treatment. We did not identify disease-related parameters associated with these effects.

Author Information


*Department of Pediatrics, University of California, Davis School of Medicine, CA

Support: Dr Gofman received a small administrative grant from the Children's Miracle Network Telethon.

Reprints: Jonathan Ducore, MD, MPH, UCDMC Pediatrics, Hematology/Oncology, TICON II Bldg, 2516 Stockton Blvd, Sacramento, CA 95817 (

Received for publication March 20, 2008; accepted August 24, 2008

© 2009 Lippincott Williams & Wilkins, Inc.